A Study to Evaluate the Efficacy of Tocilizumab as a Remission-Induction and Glucocorticoid-Sparing Regimen in Subjects With New-Onset Polymyalgia Rheumatica (PMR- SPARE)

NCT03263715 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: Tocilizumab Prefilled Syringe [Actemra]
DRUG: Placebos
DRUG: Glucocorticoids

Sponsor

Medical University of Vienna